Home Institutions Northwestern Medicine clinical trials Institution Directory
Clinical trials at Northwestern Medicine Sites in Chicago, IL
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 31, 2026, 10:47 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1129
Current sort
Recently updated
Campus scope
Northwestern Medicine, Chicago, IL
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 805–816 of 1,129 matching trials with a site at Northwestern Medicine, Chicago, IL.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer
Interventions 3-Dimensional Conformal Radiation Therapy (3D-CRT), Docetaxel, Gemcitabine, Intensity-Modulated Radiation Therapy (IMRT), Pemetrexed Disodium, Stereotactic Body Radiation Therapy (SBRT), Erlotinib Hydrochloride, Pembrolizumab Radiation · Drug
Lead sponsor NRG Oncology Other
Eligibility 18 Years and older
Enrollment 218 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2028
U.S. locations 296
States / cities Birmingham, Alabama • Gilbert, Arizona • Peoria, Arizona + 228 more
Conditions Prostatic Neoplasms
Interventions 177Lu-PSMA-617, 68Ga-PSMA-11, ARDT, ADT Drug
Lead sponsor Novartis Pharmaceuticals Industry
Eligibility 18 Years to 100 Years · Male only
Enrollment 1,140 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2027
U.S. locations 70
States / cities Scottsdale, Arizona • La Jolla, California • Los Angeles, California + 50 more
Conditions Hypertension in Pregnancy, Pre-Eclampsia, Eclampsia, Gestational Hypertension
Interventions Digital Blood Pressure Monitoring System, Mobile health application Other
Lead sponsor Northwestern University Other
Eligibility 18 Years to 99 Years · Female only
Enrollment 120 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2026
U.S. locations 1
States / cities Chicago, Illinois
Conditions Stroke, Stroke Gait Rehabilitation
Interventions myoelectric interface for neurorehabilitation (MINT) conditioning, One muscle myoelectric feedback Other
Lead sponsor Northwestern University Other
Eligibility 18 Years to 85 Years
Enrollment 72 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2030
U.S. locations 2
States / cities Chicago, Illinois • Dallas, Texas
Conditions Extensive Stage Lung Small Cell Carcinoma
Interventions Atezolizumab, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Talazoparib Drug · Procedure
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 103 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 561
States / cities Anchorage, Alaska • Kingman, Arizona • Phoenix, Arizona + 362 more
Conditions Infertility, Endometriosis
Interventions Elagolix 200 MG, Placebo or SOC IVF Drug · Other
Lead sponsor Yale University Other
Eligibility 18 Years to 40 Years · Female only
Enrollment 97 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 5
States / cities Aurora, Colorado • New Haven, Connecticut • Chicago, Illinois + 2 more
Conditions Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease
Interventions Lecanemab, Placebo Drug
Lead sponsor Eisai Inc. Industry
Eligibility 55 Years to 80 Years
Enrollment 1,400 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2031
U.S. locations 72
States / cities Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 61 more
Conditions Peripheral Artery Disease, Peripheral Vascular Disease, Aging, Walking, Difficulty
Interventions Far red light therapy, Sham light therapy Device
Lead sponsor Northwestern University Other
Eligibility 50 Years and older
Enrollment 32 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2026
U.S. locations 2
States / cities Birmingham, Alabama • Chicago, Illinois
Conditions Evaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the Skin
Interventions Experimental J-Tip Needle-Free Injection System, Control (Standard treatment) Device
Lead sponsor Northwestern University Other
Eligibility 18 Years and older
Enrollment 110 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 1
States / cities Chicago, Illinois
Conditions Solid Tumor
Interventions Farletuzumab ecteribulin, Prednisone, Prednisolone, Dexamethasone, Lenvatinib Drug
Lead sponsor Eisai Inc. Industry
Eligibility 18 Years and older
Enrollment 182 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2030
U.S. locations 24
States / cities Tucson, Arizona • Little Rock, Arkansas • Palo Alto, California + 19 more
Conditions Lymphoma, Mantle Cell Lymphoma
Interventions rituximab, Bendamustine, bortezomib, lenalidomide Biological · Drug
Lead sponsor Eastern Cooperative Oncology Group Network
Eligibility 18 Years to 120 Years
Enrollment 373 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2012 – 2031
U.S. locations 416
States / cities Anchorage, Alaska • Antioch, California • Fremont, California + 283 more
Conditions Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Interventions Biospecimen Collection, Capmatinib, Computed Tomography, Magnetic Resonance Imaging, Osimertinib, Ramucirumab Procedure · Drug · Biological
Lead sponsor SWOG Cancer Research Network Network
Eligibility 18 Years and older
Enrollment 66 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2028
U.S. locations 454
States / cities Daphne, Alabama • Fairhope, Alabama • Mobile, Alabama + 360 more About this Northwestern Medicine institution page
What this page lists ClinicalTrials.gov records that list Northwestern Medicine in Chicago, IL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by Northwestern University at any site , browse by condition , or browse by U.S. city .